In Reply
- PMID: 37103542
- DOI: 10.1097/AOG.0000000000005164
In Reply
Conflict of interest statement
Financial Disclosure Brian T. Nguyen disclosed that money was paid to his institution from the WHO. He received payment from Myovant Sciences and Sebela Pharmaceuticals. The other authors did not report any potential conflicts of interest.
References
-
- Nguyen MT, Campo-Engelstein L, Lee RH, Nguyen BT. An ethical argument for health insurance coverage of paternal prenatal genetic testing. Obstet Gynecol 2023;141:11–4. doi: 10.1097/AOG.0000000000005018 - DOI
-
- Giles Choates M, Stevens BK, Wagner C, Murphy L, Singletary CN, Wittman AT. It takes two: uptake of carrier screening among male reproductive partners. Prenatal Diagn 2020;40:311–6. doi: 10.1002/pd.5588 - DOI
-
- Nguyen M, Truong A, Mazza G, Nguyen B. eP461: barriers to prenatal genetic testing for male partners at a Los Angeles County public teaching hospital [abstract]. Genet Med 2022;24:S289–91. doi: 10.1016/j.gim.2022.01.494 - DOI
-
- Reed K. 'It's them faulty genes again': women, men and the gendered nature of genetic responsibility in prenatal blood screening. Sociol Health Illness 2009;31:343–59. doi: 10.1111/j.1467-9566.2008.01134.x - DOI
-
- Reed K. 'He's the dad isn't he?' Gender, race and the politics of prenatal screening. Ethn Health 2011;16:327–41. doi: 10.1080/13557858.2010.531196 - DOI
LinkOut - more resources
Full Text Sources